Exercise-snacks at Work: Impact on Cardiometabolic Parameters

April 15, 2025 updated by: University of Avignon

Exercise-snacks: an Effective Strategy to Break Sitting Time and Improve Cardiometbaolic Health in Sedentary Overweight Office Workers

The main objective is to measure the effects of intense brief exercise program in the workplace of administrative staff on the cardio-metabolic health

Study Overview

Detailed Description

Backgrounds: Very short (< 1 minute) and intense exercises, entitled "exercise-snacks", have been reported to be effective 1) in improving physical fitness over 6 weeks and 2) in improving vascular function and lowering blood glucose levels over one day. These studies were all carried out in the laboratory. The question therefore arises as to whether these acute vascular and metabolic benefits, as well as those on physical fitness, are sustainable over time following a chronic "exercise-snacks" program applicable in the professional environment to sedentary, overweight people.

Aims of this project is therefore to measure the effects of an "exercise-snacks" type physical activity program in the workplace of administrative staff on the cardio-metabolic health and sedentary behaviour of staff.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Avignon, France, 84000
        • Avignon University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • administrative staff,
  • age between 30 and 60,
  • body mass index ≥25kg/m²,
  • sedentary time ≥7h/day,
  • minimum 3 working days on site,
  • no known cardiovascular or metabolic pathology, social security affiliation or benefit,
  • ability and willingness to give free, written and informed consent.

Exclusion Criteria:

  • pregnant or breast-feeding women,
  • anti-hypertensive treatment, beta-blockers and anti-diabetics,
  • known contraindications to physical activity (articular, cardiac or other),
  • exercise-induced asthma,
  • lack of motivation of subjects posing problems of compliance and adherence to the exercise program,
  • participation in a study in the preceding 3 months, ongoing participation in a clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise-snacks group
They will perform a "exercise-snacks" program and receive information about physical activity
Subjects in the exercise-snacks group will perform 4 "exercise-snacks" sessions per working day for 4 weeks. These sessions will consist of 80 one-to-one walks to be completed as quickly as possible. They will also receive information about their attitudes to physical activity.
No Intervention: Control group
They will maintain their usual lifestyle until the end of the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in aerobic fitness
Time Frame: at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
Aerobic fitness will be assessed via the Chester step test's prediction of VO2max
at inclusion, at the end of the 4-weeks program and 1 month following the end of the program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence of staff in the experimental group by analyzing accelerometric data.
Time Frame: during the 4-weeks program
Total number of exercise-snacks performed during the 4-week program by analysing accelerometers data
during the 4-weeks program
Intensity of exercise-snacks
Time Frame: during the 4-weeks program
Heart rate during exercise-snacks in % heart rate max
during the 4-weeks program
Changes in flow mediated dilation of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
measured by echocardiography (Vivid Q, GE) , in %
at inclusion, at the end of the 4-weeks program
Changes in peak shear rate of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
measured by echocardiography (Vivid Q, GE) during hyperemia, in s-1
at inclusion, at the end of the 4-weeks program
Changes in nitrate mediated dilation of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
by echocardiography (Vivid Q, GE), in %
at inclusion, at the end of the 4-weeks program
Changes in superficial femoral artery compliance
Time Frame: at inclusion, at the end of the 4-weeks program
by echocardiography (Vivid Q, GE), in mm2 mmHg-1
at inclusion, at the end of the 4-weeks program
Changes in carotid intima-thickness
Time Frame: at inclusion, at the end of the 4-weeks program
by echocardiography (Vivid Q) in mm
at inclusion, at the end of the 4-weeks program
Changes in carotid compliance
Time Frame: at inclusion, at the end of the 4-weeks program
by echocardiography (Vivid Q) in mm2 mmHg-1
at inclusion, at the end of the 4-weeks program
Changes in carotid-femoral pulse wave velocity
Time Frame: at inclusion, at the end of the 4-weeks program
by Sphygmocor, in m.s-1
at inclusion, at the end of the 4-weeks program
Changes in post-occlusive skin perfusion
Time Frame: at inclusion, at the end of the 4-weeks program
by Laser Doppler (Perimed), in perfusion unit, in area under the curve, in time to peak
at inclusion, at the end of the 4-weeks program
Changes in blood pressure
Time Frame: at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
systolic, diastolic, mean and pulsed
at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
Changes in mean amplitude of glycemic excursions
Time Frame: one week before the beginning of the program and the first week of the program and the 2 lastest weeks of the program
measured by continuous glucose monitoring (FreeStyle), in mmol.L-1
one week before the beginning of the program and the first week of the program and the 2 lastest weeks of the program
Changes in heart rate
Time Frame: between the beginning and end of the 4-week exercise program and 4 weeks after the program.
Heart rate at rest, at the end of the Chester step test and during exercise
between the beginning and end of the 4-week exercise program and 4 weeks after the program.
Changes in level of habitual physical activity
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
Physical Activity questionnaire
between the start and end of the 4-week exercise program and 4 weeks after the program
Changes in fat mass
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
measured by InBody, in kg
between the start and end of the 4-week exercise program and 4 weeks after the program
Changes in lean mass
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
measured by InBody, in kg
between the start and end of the 4-week exercise program and 4 weeks after the program
Change in physical activity behaviour at work of staff
Time Frame: between the start and end of the 4-week exercise program.
Theory of planned behavior questionnaire, score range from 20 to 80 with higher scores mean a better outcome.
between the start and end of the 4-week exercise program.
Changes in rating of perceived exertion
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
measured during the Chester test, score range from 7 to 20 with higher scores mean a worse outcome.
between the start and end of the 4-week exercise program and 4 weeks after the program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Agnès VINET, Avignon University - LaPEC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2023

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

July 20, 2024

Study Registration Dates

First Submitted

June 19, 2023

First Submitted That Met QC Criteria

July 4, 2023

First Posted (Actual)

July 12, 2023

Study Record Updates

Last Update Posted (Actual)

April 20, 2025

Last Update Submitted That Met QC Criteria

April 15, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AU-062023-AVJ

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Exercise-snacks program

Subscribe